Study of how a new drug is processed in healthy men
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study examines how a new drug (called HRS-1780) is processed and eliminated by the body using a special radioactive label. It will help researchers understand the drug’s behavior to guide future studies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthy male aged 18 to 45 years.
- You weigh at least 50 kg (110 pounds) and have a BMI between 19 and 26.
- You agree not to father a child or donate sperm for 3 months after the study starts and will use contraception.
- You haven’t participated in another drug trial or used an investigational drug in the past 3 months.
- You’re not taking any prescription, over-the-counter, or herbal medications (except vitamins or occasional acetaminophen) for 2 weeks before the study.
- You don’t smoke more than 5 cigarettes a day or use nicotine products heavily.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study gives healthy people a single shot of a study drug that has a tiny radioactive label, then tracks how it moves through the body. It helps researchers learn how the drug is absorbed and removed, which is a key step before it can be tested as a possible treatment for weight-related conditions.
This study looks at how a new medicine is broken down and removed from the body in healthy men. It helps researchers understand the drug's safety and how it works.
This study is testing how a new drug is processed by the body in healthy men. It will help researchers understand the drug's effects and safety before it is tested in patients.
This trial tests an investigational drug called HRS-1780 in people with chronic kidney disease. It aims to see if the drug can help slow kidney decline and is safe to use.
This study is testing a new injectable medicine (HRS-4729) to see how the body processes it in people with healthy kidneys and in those with kidney problems. If you join, you will receive a single dose and have your blood and urine checked over time to measure the drug levels.
This study is for healthy men to see how a new experimental drug moves through the body and leaves it. The drug contains a tiny amount of radiation, which helps researchers track it safely.
Hear when a new Chronic Kidney Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.